TLR4 regulates RORγt+ regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila

被引:105
|
作者
Liu, Yaojiang [1 ,2 ]
Yang, Min [1 ]
Tang, Li [1 ]
Wang, Fengchao [3 ]
Huang, Shengjie [2 ]
Liu, Shuang [1 ]
Lei, Yuanyuan [1 ]
Wang, Sumin [1 ]
Xie, Zhuo [1 ]
Wang, Wei [1 ]
Zhao, Xiaoyan [1 ]
Tang, Bo [1 ]
Yang, Shiming [1 ]
机构
[1] Third Mil Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Chongqing 400037, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Chongqing 400010, Peoples R China
[3] Third Mil Med Univ, Coll Prevent Med, Inst Combined Injury, State Key Lab Trauma Burns & Combined Injury, Chongqing 400037, Peoples R China
基金
中国国家自然科学基金;
关键词
TOLL-LIKE RECEPTORS; GUT MICROBIOTA; BOWEL-DISEASE; IMMUNE-RESPONSES; COLITIS; PATHOGENESIS; COMMENSAL; MICE; COLONIZATION; POPULATION;
D O I
10.1186/s40168-022-01296-x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Well-balanced interactions between gut microbiota and the immune system are essential to prevent chronic intestinal inflammation, as observed in inflammatory bowel diseases (IBD). Toll-like receptor 4 (TLR4) functions as a sensor mediating the crosstalk between the intestinal commensal microbiome and host immunity, but the influence of TLR4 on the shaping of intestinal microbiota and immune responses during colon inflammation remains poorly characterized. We investigated whether the different susceptibilities to colitis between wild-type (WT) and TLR4(-/-) mice were gut microbiota-dependent and aimed to identify the potential immunity modulation mechanism. Methods: We performed antibiotic depletion of the microbiota, cohousing experiments, and faecal microbiota transplantation (FMT) in WT and TLR4(-/-) mice to assess the influence of TLR4 on intestinal microbial ecology. 16S rRNA sequencing was performed to dissect microbial discrepancies, and dysbiosis-associated immune perturbation was investigated by flow cytometry. Akkermansia muciniphila (A. muciniphila)-mediated immune modulation was confirmed through the T-cell transfer colitis model and bone marrow chimaera construction. Results: TLR4(-/-) mice experienced enhanced susceptibility to DSS-induced colitis. 16S rRNA sequencing showed notable discrepancy in the gut microbiota between WT and TLR4(-/-) mice. In particular, A. muciniphila contributed most to distinguishing the two groups. The T-cell transfer colitis model and bone marrow transplantation (BMT) consistently demonstrated that A. muciniphila ameliorated colitis by upregulating ROR gamma t(+) Treg cell-mediated immune responses. Mucosal biopsies from human manifested parallel outcomes with colon tissue from WT mice, as evidenced by the positive correlation between TLR4 expression and intestinal A. muciniphila colonization during homeostasis. Conclusions: Our results demonstrate a novel protective role of TLR4 against intestinal inflammation, wherein it can modulate A. muciniphila-associated immune responses. These findings provide a new perspective on host-commensal symbiosis, which may be beneficial for developing potential therapeutic strategies. [GRAPHICS] .
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets
    Wei, B
    Velazquez, P
    Turovskaya, O
    Spricher, K
    Aranda, R
    Kronenberg, M
    Birnbaumer, L
    Braun, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (06) : 2010 - 2015
  • [32] CD4+ T regulatory cell induction and function in transplant recipients after CD154 blockade is TLR4 independent
    Zhai, Yuan
    Meng, Lingzhong
    Gao, Feng
    Wang, Yue
    Busuttil, Ronald W.
    Kupiec-Weglinski, Jerzy W.
    JOURNAL OF IMMUNOLOGY, 2006, 176 (10): : 5988 - 5994
  • [33] ATF4 Regulates CD4+ T Cell Immune Responses through Metabolic Reprogramming
    Yang, Xi
    Xia, Rui
    Yue, Cuihua
    Zhai, Wensi
    Du, Wenwen
    Yang, Qianting
    Cao, Huiling
    Chen, Xiaojuan
    Obando, Danielle
    Zhu, Yibei
    Chen, Xinchun
    Chen, Jane-Jane
    Piganelli, Jon
    Wipf, Peter
    Jiang, Yu
    Xiao, Guozhi
    Wu, Changping
    Jiang, Jingting
    Lu, Binfeng
    CELL REPORTS, 2018, 23 (06): : 1754 - 1766
  • [34] Type IIFN negatively regulates CD8+ T cell responses through IL-10-Producing CD4+ T regulatory 1 cells
    Dikopoulos, N
    Bertoletti, A
    Kröger, A
    Hauser, H
    Schirmbeck, R
    Reimann, J
    JOURNAL OF IMMUNOLOGY, 2005, 174 (01): : 99 - 109
  • [35] Diminished TLR2-TLR9 mediated CD4+T cell responses are associated with increased inflammation in intraocular tuberculosis
    Sharma, Ravi Kumar
    Sharma, Jyoti
    Khan, Zafar K.
    Pattekar, Ajinkya
    Gupta, Vishali
    Bansal, Reema
    Sharma, Kusum
    Aggarwal, Ashutosh Nath
    Gupta, Amod
    Sachdeva, Naresh
    SCIENTIFIC REPORTS, 2018, 8
  • [36] Diminished TLR2-TLR9 mediated CD4+ T cell responses are associated with increased inflammation in intraocular tuberculosis
    Ravi Kumar Sharma
    Jyoti Sharma
    Zafar K. Khan
    Ajinkya Pattekar
    Vishali Gupta
    Reema Bansal
    Kusum Sharma
    Ashutosh Nath Aggarwal
    Amod Gupta
    Naresh Sachdeva
    Scientific Reports, 8
  • [37] Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses
    Rudilla, Francesc
    Fayolle, Catherine
    Casares, Noelia
    Durantez, Maika
    Arribillaga, Laura
    Lozano, Teresa
    Villanueva, Lorea
    Pio, Ruben
    Sarobe, Pablo
    Leclerc, Claude
    Prieto, Jesus
    Jose Lasarte, Juan
    VACCINE, 2012, 30 (18) : 2848 - 2858
  • [38] Cytotoxicity of FK506 through TRAIL, Fas and TLR4 signaling pathway in human jurkat T Cell4
    Choi, Soo Jin Na
    Jung, Hong Sung
    TRANSPLANTATION, 2024, 108 (9S)
  • [39] Cytotoxicity of FK506 through TRAIL, Fas and TLR4 signaling pathway in human jurkat T Cell4
    Choi, Soo Jin Na
    Jung, Hong Sung
    TRANSPLANTATION, 2024, 108 (09) : 489 - 489
  • [40] Cancer vaccination reprograms regulatory T cells into helper CD4 T cells to promote antitumor CD8 T-cell responses
    Chai, Jian-Guo
    IMMUNOTHERAPY, 2011, 3 (05) : 601 - 604